Watch this on-demand webinar to discover how combining drug substance (DS) and drug product (DP) manufacturing within Lonza’s CDMO framework can streamline biologics development. Experts Raminder Bahia and Fabien Walas share insights from cross-site DS/DP projects, highlighting how integration improves coordination, quality, and regulatory outcomes.
Learn how early DS/DP alignment, harmonized tech transfers, and shared quality systems help resolve manufacturing challenges and meet timelines across Lonza’s global network.
Key Takeaways
- Ensure product integrity and regulatory readiness through site coordination.
- Align DS and DP activities via integrated project management.
- Accelerate timelines with shared systems and flexible resource deployment.
Complete the form to watch now.
Author(s):
Fabien Walas
Senior Technology Transfer Lead DPS
Raminder Bahia, PhD
Group Lead, Director of Program Management